台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    87.7
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    471
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智擎 (4162)籌碼相關-永豐金-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/07286.90287.4587.7001,4730.00%
2025/05/06186.90187.6087.7001,6570.00%
2025/05/05586.78487.2387.7011,7640.06%
2025/04/30790.801889.5489.20-111,796-0.61%
2025/04/291291.1400.0091.00121,7910.67%
2025/04/2800.00390.0790.50-31,790-0.17%
2025/04/25487.85188.1087.9031,7790.17%
2025/04/241.287.87288.2087.70-0.81,774-0.05%
2025/04/23387.23487.4087.40-11,773-0.06%
2025/04/22385.83386.0085.5001,7770.00%
2025/04/21686.93286.3585.8041,7750.23%
2025/04/1800.00189.3088.90-11,784-0.06%
2025/04/17186.10286.8589.40-11,792-0.06%
2025/04/16388.10288.0587.1011,8170.06%
2025/04/15286.302087.3689.20-181,828-0.98%
2025/04/14285.301885.9385.10-161,833-0.87%
2025/04/112582.95183.9084.00241,8421.30%
2025/04/1000.00283.7084.10-21,846-0.11%
2025/04/0913.578.69180.6076.5012.51,8440.68%
2025/04/08381.67281.6584.6011,8010.06%
2025/04/070.189.0000.0089.000.11,7660.01%
2025/04/02197.30197.9098.8001,7700.00%
2025/04/01497.70398.0797.3011,7730.06%
2025/03/31596.68596.8896.2001,7710.00%
2025/03/283100.673101.00100.5001,7520.00%
2025/03/2000.001105.50106.00-11,713-0.06%
2025/03/192104.501105.00104.5011,7180.06%
2025/03/170106.0000.00105.0001,7140.00%
2025/03/140105.502104.50105.00-21,713-0.12%
2025/03/132104.002104.00103.5001,7070.00%
2025/03/121106.501107.50107.0001,6950.00%
2025/03/110.3106.501105.00107.00-0.71,697-0.04%
2025/03/101105.501106.00107.0001,6860.00%
2025/03/072.5108.700.1107.50107.502.41,6650.15%
2025/03/063112.330112.00111.0031,6470.18%
2025/03/050114.002115.00115.50-21,645-0.12%
2025/03/042112.5021112.07114.50-191,634-1.16%
2025/03/030113.8824112.75112.50-241,620-1.48%
2025/02/2726112.601110.00109.00251,5681.59%
2025/02/2622.3115.375119.00115.5017.31,5531.11%
2025/02/251113.0000.00113.0011,4430.07%
2025/02/2400.001114.50115.00-11,431-0.07%
2025/02/210.2112.501113.50113.00-0.81,412-0.06%
2025/02/191110.000.2110.26110.000.81,3960.05%
2025/02/181110.000.3109.50110.000.81,4010.05%
2025/02/171112.501113.50112.5001,3970.00%
2025/02/1400.0011.5110.28111.50-11.51,408-0.82%
2025/02/130.5111.0000.00111.500.51,4130.04%
2025/02/1200.001112.00112.00-11,408-0.07%
2025/02/115.5112.0500.00109.005.51,3920.39%
2025/02/100119.001118.00118.50-11,337-0.07%
2025/02/073119.005.2119.40120.50-2.21,351-0.17%
2025/02/0614119.2514.1119.89119.00-0.11,3290.00%
2025/02/057.2110.761.4111.07113.005.81,1940.49%
2025/02/043103.001102.00103.0021,2010.17%
2025/01/22096.0000.0096.1001,1930.00%
2025/01/10195.60196.6097.0001,3550.00%
2025/01/09298.205595.9994.60-531,341-3.95%
2025/01/0800.001103.00103.00-11,299-0.08%
2025/01/072100.503101.33101.50-11,275-0.08%
2025/01/06199.5000.00101.5011,2590.08%
2025/01/03296.50496.7898.30-21,240-0.16%
2024/12/30192.3000.0091.0011,2240.08%
2024/12/272692.7800.0092.00261,2232.13%
2024/12/262693.3700.0092.50261,2252.12%
2024/12/2500.00988.1291.00-91,214-0.74%
2024/12/24988.20788.0087.4021,2070.17%
2024/12/23187.0000.0087.0011,2100.08%
2024/12/11191.6000.0090.6011,1930.08%
2024/12/04195.0000.0094.6011,1640.09%
2024/12/03194.6000.0094.4011,1610.09%
2024/11/133106.001106.50106.5029460.21%
2024/11/1200.000.1100.50104.00-0.1916-0.01%
2024/11/0800.002.1102.97103.00-2.1873-0.24%
2024/11/072105.2500.00103.5028520.23%
2024/11/061.1108.432105.00102.50-1826-0.11%
2024/11/0500.001108.00106.00-1782-0.13%
2024/11/012109.000.1107.26105.001.97300.26%
2024/10/3000.001102.00102.00-1617-0.16%
2024/10/292100.502101.50100.5006040.00%
2024/10/2800.001102.90102.00-1576-0.18%
2024/10/242.199.31298.2598.300.14940.02%
2024/10/2300.00194.4093.70-1424-0.24%
2024/10/07088.8300.0088.8005060.00%
2024/10/04089.10088.7088.7005410.00%
2024/10/01088.9000.0089.9005450.00%
2024/09/3000.000.189.6089.50-0.1550-0.01%
2024/09/1900.00186.0086.00-1636-0.16%
2024/09/130.182.8000.0082.200.16440.01%
2024/08/23086.0000.0085.9007400.00%
2024/08/22086.8000.0086.6007400.00%
2024/08/2000.00185.5085.80-1742-0.13%
2024/08/1900.00184.6084.50-1739-0.14%
2024/07/31193.6000.0093.2017360.14%
2024/07/2300.00193.9094.50-1720-0.14%
2024/07/22194.3000.0092.0017180.14%
2024/07/1900.001.595.7794.20-1.5708-0.21%
2024/07/1700.000.298.4498.20-0.2658-0.03%
2024/07/160.196.7000.0097.000.16580.02%
2024/07/150.299.2000.0098.400.26630.03%
2024/07/1200.00196.1095.60-1648-0.15%
2024/07/090.296.9100.0096.300.26680.02%
2024/07/080.199.900.5100.00100.50-0.5655-0.07%
2024/07/0400.00596.0096.00-5626-0.80%
2024/07/0300.000.196.6096.70-0.1628-0.01%
2024/07/020.199.5000.0097.800.16230.01%
2024/06/26198.0000.0097.6015760.17%
2024/06/2500.00192.6094.30-1568-0.18%
2024/06/18095.7000.0095.4006330.00%
2024/06/13197.1000.0096.9016510.15%
2024/06/11095.3000.0095.4006360.00%
2024/05/27191.6000.0091.7017760.13%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章